Citation Impact
Citing Papers
Method validation strategies involved in non-targeted metabolomics
2014
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
Plasma S/R ratio of warfarin co-varies with VKORC1 haplotype
2007 StandoutNobel
Polymorphism of human cytochrome P450 enzymes and its clinical impact
2009
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Oral Anticoagulant Therapy
2012 Standout
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
2002
Intravital imaging to study cancer progression and metastasis
2022
A systematic genetic polymorphism analysis of the CYP2C9 gene in four different geographical Han populations in mainland China
2010
Cytochrome P450 2C9 polymorphisms: a comprehensive review of the in-vitro and human data
2002
Management of validation of HPLC method for determination of acetylsalicylic acid impurities in a new pharmaceutical product
2022 Standout
Systematic polymorphism analysis of the CYP2D6 gene in four different geographical Han populations in mainland China
2008
Hydrophilic interaction chromatography
2006 Standout
STEREOSELECTIVE METABOLISM OF LANSOPRAZOLE BY HUMAN LIVER CYTOCHROME P450 ENZYMES
2003
The Effect of CYP2C19 Polymorphism on the Pharmacokinetics and Pharmacodynamics of Clopidogrel: A Possible Mechanism for Clopidogrel Resistance
2008
CYP2C19 Polymorphism and Proton Pump Inhibitors
2004
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Development and validation of a hydrophilic interaction liquid chromatography–tandem mass spectrometric method for the analysis of paroxetine in human plasma
2003
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
CYP2C9 polymorphism and warfarin sensitivity in Taiwan Chinese
2006
Activation of H2O2 by Chiral Confined Brønsted Acids: A Highly Enantioselective Catalytic Sulfoxidation
2012 StandoutNobel
Cytochrome P450-Mediated Drug Interactions
2000
Pharmacogenetic testing among patients with mood and anxiety disorders is associated with decreased utilization and cost: A propensity-score matched study
2018 StandoutNobel
Asymmetric Counteranion‐Directed Iron Catalysis: A Highly Enantioselective Sulfoxidation
2012 StandoutNobel
Applications of Catalytic Asymmetric Sulfide Oxidations to the Syntheses of Biologically Active Sulfoxides
2005
Pharmaceuticals of Emerging Concern in Aquatic Systems: Chemistry, Occurrence, Effects, and Removal Methods
2019 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Fluorine in health care: Organofluorine containing blockbuster drugs
2010 Standout
Visible‐Light Photocatalysis: Does It Make a Difference in Organic Synthesis?
2018 Standout
Hydrolysis and photolysis of paroxetine, a selective serotonin reuptake inhibitor, in aqueous solutions
2004
CLINICAL AND TOXICOLOGICAL RELEVANCE OF CYP2C9: Drug-Drug Interactions and Pharmacogenetics
2005
Works of Young‐Ran Yoon being referenced
Rapid simple high-performance liquid chromatographic determination of paroxetine in human plasma
1998
Effect of Rifampin on the Plasma Concentration and the Clinical Effect of Haloperidol Concomitantly Administered to Schizophrenic Patients
1996
Revival of TE2A; a better chelate for Cu(II) ions than TETA?
2010
Frequency of cytochrome P450 2C9 mutant alleles in a Korean population
2001
Enantioselective disposition of lansoprazole in extensive and poor metabolizers of CYP2C19
2002
Understanding the pharmacokinetics of prodrug and metabolite
2018
Pattern Recognition Analysis for Hepatotoxicity Induced by Acetaminophen Using Plasma and Urinary 1H NMR-Based Metabolomics in Humans
2013
Non-Cross-Bridged Tetraazamacrocyclic Chelator for Stable 64Cu-Based Radiopharmaceuticals
2013